Abstract
With our ability to integrate an ever-wider range of physiologically inspired functions into an organ-on-a-chip, we can customize devices to be increasingly fit for purpose. For instance, intestine-on-chip (or gut-on-chip) devices have to date focused on mimicking the in vivo intercellular interactions at the intestinal wall that
control the absorption of compounds over this biological interface.
However, the compound of interest arrives at the intestine after having been ingested as a medicine containing excipients or as a food
matrix. Enzymatic digestion serves to release and change the form
of the compound as it passes from the mouth through the stomach
to the intestine. Therefore, to study the uptake of novel drugs, toxicants, or food materials, a fit for purpose organ-chip should include
an in vitro digestive system in addition to intestinal absorption, to
provide valid information on bioavailability (the fraction of compound that finally reaches the bloodstream).
The work described here considers on-chip digestion, a process
requiring multiple functions, for eventual integration with a guton-a-chip. After earlier work that mimicked adult digestive processes [1], we now present a versatile system to emulate the digestion of infants. We translated a static, batch-wise, in vitro digestive
system for à terme infants [2] into a continuously flowing, infantile, digestive system. Sequentially linked microfluidic micromixers were employed as microreactors to perform specific digestive
processes. Artificial digestive juices were prepared at defined compositions and pH, to ensure exact physiological conditions at each
stage (microreactor) of infantile digestion. All of the flows in the
on-chip digestive system and the gut-on-a-chip were maintained by
a novel flow control system, based on Coriolis mass flow sensors
to maintain exact flow rates irrespective of digestive-juice properties [3]. Operation of the organ-chip was possible for a period of
13 days with no replacement of medium reservoirs required. We
demonstrate the digestion of lactoferrin benchmarked against currently used in vitro digestion models.
References
[1] de Haan et al. (2019). Lab Chip. doi:10.1039/C8LC01080C
[2] Ménard et al. (2018). Food Chem. doi:10.1016/j.foodchem.2017.07.145
[3] Sparreboom et al. (2013). Micromachines. doi:10.3390/
mi4010022
control the absorption of compounds over this biological interface.
However, the compound of interest arrives at the intestine after having been ingested as a medicine containing excipients or as a food
matrix. Enzymatic digestion serves to release and change the form
of the compound as it passes from the mouth through the stomach
to the intestine. Therefore, to study the uptake of novel drugs, toxicants, or food materials, a fit for purpose organ-chip should include
an in vitro digestive system in addition to intestinal absorption, to
provide valid information on bioavailability (the fraction of compound that finally reaches the bloodstream).
The work described here considers on-chip digestion, a process
requiring multiple functions, for eventual integration with a guton-a-chip. After earlier work that mimicked adult digestive processes [1], we now present a versatile system to emulate the digestion of infants. We translated a static, batch-wise, in vitro digestive
system for à terme infants [2] into a continuously flowing, infantile, digestive system. Sequentially linked microfluidic micromixers were employed as microreactors to perform specific digestive
processes. Artificial digestive juices were prepared at defined compositions and pH, to ensure exact physiological conditions at each
stage (microreactor) of infantile digestion. All of the flows in the
on-chip digestive system and the gut-on-a-chip were maintained by
a novel flow control system, based on Coriolis mass flow sensors
to maintain exact flow rates irrespective of digestive-juice properties [3]. Operation of the organ-chip was possible for a period of
13 days with no replacement of medium reservoirs required. We
demonstrate the digestion of lactoferrin benchmarked against currently used in vitro digestion models.
References
[1] de Haan et al. (2019). Lab Chip. doi:10.1039/C8LC01080C
[2] Ménard et al. (2018). Food Chem. doi:10.1016/j.foodchem.2017.07.145
[3] Sparreboom et al. (2013). Micromachines. doi:10.3390/
mi4010022
Original language | English |
---|---|
Pages | 367-368 |
Publication status | Published - 26-Jun-2023 |
Event | MPS World Summit 2023 - Berlin, Germany Duration: 26-Jun-2023 → 30-Jun-2023 Conference number: 2 https://proceedings.altex.org/data/2023-01/altex_MPS2.pdf |
Conference
Conference | MPS World Summit 2023 |
---|---|
Country/Territory | Germany |
City | Berlin |
Period | 26/06/2023 → 30/06/2023 |
Internet address |